Xiaobing Lan

1.3k total citations · 1 hit paper
42 papers, 777 citations indexed

About

Xiaobing Lan is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Xiaobing Lan has authored 42 papers receiving a total of 777 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 7 papers in Physiology. Recurrent topics in Xiaobing Lan's work include Neuropeptides and Animal Physiology (8 papers), Pain Mechanisms and Treatments (7 papers) and Neonatal and fetal brain pathology (6 papers). Xiaobing Lan is often cited by papers focused on Neuropeptides and Animal Physiology (8 papers), Pain Mechanisms and Treatments (7 papers) and Neonatal and fetal brain pathology (6 papers). Xiaobing Lan collaborates with scholars based in China, Canada and South Korea. Xiaobing Lan's co-authors include Shaoyong Lu, Xun Lu, Kai Chen, Ting Chen, Jian‐Qiang Yu, Jiamei Yang, Lin Ma, Jianqiang Yu, Jianguo Niu and Tao Sun and has published in prestigious journals such as Nature Communications, Neuroscience and Journal of Medicinal Chemistry.

In The Last Decade

Xiaobing Lan

40 papers receiving 775 citations

Hit Papers

G protein-coupled receptors (GPCRs): advances in structur... 2024 2026 2025 2024 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaobing Lan China 15 380 107 83 73 73 42 777
Yingying Luo China 18 508 1.3× 95 0.9× 112 1.3× 45 0.6× 65 0.9× 50 1.0k
Jacqueline Alves Leite Brazil 15 280 0.7× 72 0.7× 57 0.7× 74 1.0× 114 1.6× 27 751
Baojian Guo China 16 260 0.7× 97 0.9× 106 1.3× 86 1.2× 38 0.5× 26 674
Juanjuan Yan China 18 445 1.2× 60 0.6× 65 0.8× 119 1.6× 76 1.0× 38 994
Shareen Singh India 12 267 0.7× 82 0.8× 103 1.2× 136 1.9× 52 0.7× 33 654
Kar‐Lok Wong Taiwan 20 463 1.2× 120 1.1× 103 1.2× 119 1.6× 66 0.9× 53 1.0k
Shuping Zhang China 21 493 1.3× 74 0.7× 175 2.1× 67 0.9× 145 2.0× 47 996
Mohammad Yasin Zamanian Iran 18 225 0.6× 64 0.6× 41 0.5× 98 1.3× 61 0.8× 49 621
Nawab John Dar India 13 290 0.8× 77 0.7× 111 1.3× 134 1.8× 69 0.9× 29 868

Countries citing papers authored by Xiaobing Lan

Since Specialization
Citations

This map shows the geographic impact of Xiaobing Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobing Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobing Lan more than expected).

Fields of papers citing papers by Xiaobing Lan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobing Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobing Lan. The network helps show where Xiaobing Lan may publish in the future.

Co-authorship network of co-authors of Xiaobing Lan

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobing Lan. A scholar is included among the top collaborators of Xiaobing Lan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobing Lan. Xiaobing Lan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yongliang, Xiaobing Lan, Ning Liu, et al.. (2024). Traditional Chinese medicines derived natural inhibitors of ferroptosis on ischemic stroke. Chinese Journal of Natural Medicines. 22(8). 746–755. 1 indexed citations
2.
Chen, Ting, et al.. (2024). G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery. Signal Transduction and Targeted Therapy. 9(1). 88–88. 171 indexed citations breakdown →
3.
Li, Wenxue, J. Li, Fengkai Sun, et al.. (2024). Electrochemical Oxidative Hydroxychalcogenation of Olefins with Disulfides/Thiols/Diselenides and H2O as Nucleophilic Oxygen Sources. European Journal of Organic Chemistry. 28(7).
4.
An, Zhenyu, Fengkai Sun, Xiaobing Lan, et al.. (2024). Copper-catalyzed oxidative cyclization of 2-(1H-pyrrol-1-yl)aniline and alkylsilyl peroxides: a route to pyrrolo[1,2-a]quinoxalines. Organic & Biomolecular Chemistry. 22(12). 2370–2374. 3 indexed citations
5.
Li, Wenxue, Xueying Yang, Fengkai Sun, et al.. (2024). Solvent-controlled C2/C3-regioselective ring-opening/coupling of aziridines with amines and CS 2 : synthesis of 2-aminoethyl dithiocarbamates. Organic Chemistry Frontiers. 12(4). 1266–1273. 2 indexed citations
6.
Lan, Xiaobing, et al.. (2024). Delineating the stepwise millisecond allosteric activation mechanism of the class C GPCR dimer mGlu5. Nature Communications. 15(1). 7519–7519. 14 indexed citations
7.
Zhang, Guodong, et al.. (2024). HDAC inhibitors as a potential therapy for chemotherapy-induced neuropathic pain. Inflammopharmacology. 32(4). 2153–2175. 6 indexed citations
8.
9.
Gao, Yuan, Ning Liu, Wei Wei, et al.. (2024). Mechanism of NLRP3 Inflammasome in Epilepsy and Related Therapeutic Agents. Neuroscience. 546. 157–177. 14 indexed citations
10.
Zhang, Mingyang, Xiaobing Lan, Xiaolong Li, & Shaoyong Lu. (2023). Pharmacologically targeting intracellular allosteric sites of GPCRs for drug discovery. Drug Discovery Today. 28(12). 103803–103803. 14 indexed citations
11.
Xu, Xinyuan, Qian Zhang, Xufeng Wang, et al.. (2023). Discovery of a potent and highly selective inhibitor of SIRT6 against pancreatic cancer metastasis in vivo. Acta Pharmaceutica Sinica B. 14(3). 1302–1316. 9 indexed citations
12.
Liu, Shan, Xiaobing Lan, Miaomiao Tian, et al.. (2023). Targeting the chemokine ligand 2–chemokine receptor 2 axis provides the possibility of immunotherapy in chronic pain. European Journal of Pharmacology. 947. 175646–175646. 4 indexed citations
13.
Sun, Fengkai, Wenxue Li, Xiaobing Lan, et al.. (2023). Electrochemical oxidative dehydrogenative annulation of 1-(2-aminophenyl)pyrroles with cleavage of ethers to synthesize pyrrolo[1,2-a]quinoxaline derivatives. Organic & Biomolecular Chemistry. 22(3). 472–476. 5 indexed citations
14.
Lu, Xun, Xiaobing Lan, Shaoyong Lu, & Jian Zhang. (2023). Progressive computational approaches to facilitate decryption of allosteric mechanism and drug discovery. Current Opinion in Structural Biology. 83. 102701–102701. 3 indexed citations
15.
Lan, Xiaobing, et al.. (2023). Allosteric modulation of G protein-coupled receptors as a novel therapeutic strategy in neuropathic pain. Acta Pharmaceutica Sinica B. 14(1). 67–86. 16 indexed citations
16.
Cui, Yan‐Hong, Lin Ma, Wenjing Dong, et al.. (2023). Asperosaponin VI protects against spermatogenic dysfunction in mice by regulating testicular cell proliferation and sex hormone disruption. Journal of Ethnopharmacology. 320. 117463–117463. 2 indexed citations
17.
Tian, Miaomiao, Yuxiang Li, Shan Liu, et al.. (2021). Glycosides for Peripheral Neuropathic Pain: A Potential Medicinal Components. Molecules. 27(1). 255–255. 11 indexed citations
18.
Yang, Jiamei, Lin Ma, Xiaobing Lan, et al.. (2020). Interplay between male reproductive system dysfunction and the therapeutic effect of flavonoids. Fitoterapia. 147. 104756–104756. 34 indexed citations
19.
Liu, Yue, Hui Wang, Ning Liu, et al.. (2019). Oxymatrine protects neonatal rat against hypoxic-ischemic brain damage via PI3K/Akt/GSK3β pathway. Life Sciences. 254. 116444–116444. 30 indexed citations
20.
Peng, Li, Guicheng Zhang, Xiaobing Lan, et al.. (2010). The highly potent and selective dipeptidyl peptidase IV inhibitors bearing a thienopyrimidine scaffold effectively treat type 2 diabetes. European Journal of Medicinal Chemistry. 46(1). 71–76. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026